» Authors » Adam C Raikes

Adam C Raikes

Explore the profile of Adam C Raikes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mi Y, Qi G, Vitali F, Shang Y, Raikes A, Wang T, et al.
Nat Metab . 2023 Mar; 5(3):445-465. PMID: 36959514
Astrocytes provide key neuronal support, and their phenotypic transformation is implicated in neurodegenerative diseases. Metabolically, astrocytes possess low mitochondrial oxidative phosphorylation (OxPhos) activity, but its pathophysiological role in neurodegeneration remains...
2.
McLean J, Bhattrai A, Vitali F, Raikes A, Wiegand J, Brinton R
Learn Mem . 2022 Oct; 29(9):321-331. PMID: 36206387
Age, genetics, and chromosomal sex have been identified as critical risk factors for late-onset Alzheimer's disease (LOAD). The predominant genetic risk factor for LOAD is the apolipoprotein E allele (),...
3.
Raikes A, Hernandez G, Mullins V, Wang Y, Lopez C, Killgore W, et al.
Front Neurol . 2022 Oct; 13:891531. PMID: 36188406
Context: Repetitive sub-concussive head impacts (RSHIs) are common in American football and result in changes to the microstructural integrity of white matter. Both docosahexaenoic acid (DHA) and eicosapentaoic acid (EPA)...
4.
Mullins V, Graham S, Cummings D, Wood A, Ovando V, Skulas-Ray A, et al.
Nutrients . 2022 May; 14(10). PMID: 35631280
There are limited studies on neuroprotection from repeated subconcussive head impacts (RSHI) following docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) supplementation in contact sports athletes. We performed a randomized, placebo-controlled,...
5.
Raikes A, Hernandez G, Matthews D, Lukic A, Law M, Shi Y, et al.
Alzheimers Dement (N Y) . 2022 Mar; 8(1):e12258. PMID: 35310526
Introduction: Allopregnanolone (ALLO), an endogenous neurosteroid, promoted neurogenesis and oligogenesis and restored cognitive function in animal models of Alzheimer's disease (AD). Based on these discovery research findings, we conducted a...
6.
Bajaj S, Raikes A, Razi A, Miller M, Killgore W
J Cent Nerv Syst Dis . 2021 Jun; 13:11795735211015076. PMID: 34104033
Background: Emerging evidence suggests that post concussive symptoms, including mood changes, may be improved through morning blue-wavelength light therapy (BLT). However, the neurobiological mechanisms underlying these effects remain unknown. We...
7.
Alkozei A, Dailey N, Bajaj S, Vanuk J, Raikes A, Killgore W
Front Neurol . 2021 Apr; 12:625443. PMID: 33841300
Blue wavelength light has been used successfully as a treatment method for certain mood disorders, but, the underlying mechanisms behind the mood enhancing effects of light remain poorly understood. We...
8.
Raikes A, Dailey N, Forbeck B, Alkozei A, Killgore W
Front Neurol . 2021 Feb; 12:625431. PMID: 33633674
Mild traumatic brain injuries (mTBIs) are associated with novel or worsened sleep disruption. Several studies indicate that daily morning blue light therapy (BLT) is effective for reducing post-mTBI daytime sleepiness...
9.
Killgore W, Dailey N, Raikes A, Vanuk J, Taylor E, Alkozei A
Neurosci Lett . 2020 Jul; 735:135242. PMID: 32652208
Exposure to light, particularly blue-wavelength light, has been shown to acutely increase brain activation, alertness, and some elementary aspects of cognitive performance such as working memory and emotional anticipation. Whether...
10.
Raikes A, Dailey N, Shane B, Forbeck B, Alkozei A, Killgore W
J Head Trauma Rehabil . 2020 May; 35(5):E405-E421. PMID: 32472836
Objective: Identify the treatment effects of 6 weeks of daily 30-minute sessions of morning blue light therapy compared with placebo amber light therapy in the treatment of sleep disruption following...